{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:55:45Z","timestamp":1761897345247},"reference-count":0,"publisher":"Dustri-Verlgag Dr. Karl Feistle","issue":"09","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CP"],"published-print":{"date-parts":[[2020,9,1]]},"DOI":"10.5414\/cp203849","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T13:32:17Z","timestamp":1596115937000},"page":"475-481","source":"Crossref","is-referenced-by-count":14,"title":["Prescription rates of cardiovascular and diabetes therapies prior to and during the COVID-19 lockdown in Germany"],"prefix":"10.5414","volume":"58","author":[{"given":"Karel","family":"Kostev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Konrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Bohlken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3374","container-title":["Int. Journal of Clinical Pharmacology and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T12:31:08Z","timestamp":1599222668000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dustri.com\/article_response_page.html?artId=187020&doi=10.5414\/CP203849&L=0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":0,"journal-issue":{"issue":"09","published-print":{"date-parts":[[2020]]}},"alternative-id":["203849"],"URL":"https:\/\/doi.org\/10.5414\/cp203849","relation":{},"ISSN":["0946-1965"],"issn-type":[{"value":"0946-1965","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,1]]}}}